Sourav Kalra
Sourav Kalra
Research Associate, National Institute of Pharmaceutical Education and Research Mohali
No verified email
TitleCited byYear
THPdb: database of FDA-approved peptide and protein therapeutics
SS Usmani, G Bedi, JS Samuel, S Singh, S Kalra, P Kumar, AA Ahuja, ...
PloS one 12 (7), 2017
Structural insights of cyclin dependent kinases: implications in design of selective inhibitors
S Kalra, G Joshi, A Munshi, R Kumar
European journal of medicinal chemistry 142, 424-458, 2017
Toward an understanding of structural insights of xanthine and aldehyde oxidases: an overview of their inhibitors and role in various diseases
R Kumar, G Joshi, H Kler, S Kalra, M Kaur, R Arya
Medicinal research reviews 38 (4), 1073-1125, 2018
Mechanism-based inactivation of cytochromes by furan epoxide: unraveling the molecular mechanism
N Taxak, S Kalra, PV Bharatam
Inorganic chemistry 52 (23), 13496-13508, 2013
Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation
G Joshi, H Nayyar, S Kalra, P Sharma, A Munshi, S Singh, R Kumar
Chemical biology & drug design 90 (5), 995-1006, 2017
Relay tricyclic Pd (ii)/Ag (i) catalysis: design of a four-component reaction driven by nitrene-transfer on isocyanide yields inhibitors of EGFR
DM Sawant, S Sharma, RS Pathare, G Joshi, S Kalra, S Sukanya, ...
Chemical communications 54 (82), 11530-11533, 2018
Albumin stabilized silver nanoparticles–clotrimazole β-cyclodextrin hybrid nanocomposite for enriched anti-fungal activity in normal and drug resistant Candida cells
C Gaurav, G Nikhil, S Deepti, S Kalra, R Goutam, GK Amit
RSC Advances 5 (87), 71190-71202, 2015
In silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship …
N Kumar, SS Mishra, CS Sharma, HP Singh, S Kalra
Journal of Biomolecular Structure and Dynamics 36 (7), 1691-1712, 2018
Modeling of antitubercular activity of biphenyl analogs of 2-nitroimidazo [2, 1-b][1, 3] oxazine to rationalize their activity profile
S Kalra, A Kumar, MK Gupta
Medicinal Chemistry Research 22 (7), 3444-3451, 2013
Role of genomic alterations in HER2 positive breast carcinoma: focus on susceptibility and trastuzumab-therapy
H Singla, S Kalra, P Kheterpal, V Kumar, A Munshi
Current cancer drug targets 17 (4), 344-356, 2017
Computational investigation of binding mechanism of substituted pyrazinones targeting corticotropin releasing factor-1 receptor deliberated for anti-depressant drug design
MS Shekhar, T Venkatachalam, CS Sharma, H Pratap Singh, S Kalra, ...
Journal of Biomolecular Structure and Dynamics 37 (12), 3226-3244, 2019
Anticancer activity of dihydropyrazolo[1,5‐c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase II
G Kaur, RP Cholia, G Joshi, SM Amrutkar, S Kalra, AK Mantha, ...
Archiv der Pharmazie 351 (6), 1800023, 2018
A review on quinoline derived scaffolds as anti-hiv agents
N Chokkar, S Kalra, M Chauhan, R Kumar
Mini reviews in medicinal chemistry 19 (6), 510-526, 2019
Recent advancements in mechanistic studies and structure activity relationship of FoF1 ATP synthase inhibitor as antimicrobial agent
R Narang, R Kumar, S Kalra, SK Nayak, GL Khatik, GN Kumar, ...
European journal of medicinal chemistry, 111644, 2019
Quinoline-based Protein–protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study
N Chhokar, S Kalra, M Chauhan, A Munshi, R Kumar
Current topics in medicinal chemistry 18 (32), 2800-2815, 2018
Role of 2-Dimensional Autocorrelation Descriptors in Predicting Antimalarial Activity of Artemisinin and its Aanalogues: A QSAR Study
S Kalra, G Joshi, R Kumar, A Munshi
Current topics in medicinal chemistry 18 (31), 2720-2730, 2018
Synthetic versus enzymatic pictet-spengler reaction: An overview
S Sharma, G Joshi, S Kalra, S Singh, R Kumar
Current Organic Synthesis 15 (7), 924-939, 2018
Association of CYP2C19* 2 and ALDH1A1* 1/* 2 variants with disease outcome in breast cancer patients: results of a global screening array
S Kalra, RP Kaur, A Ludhiadch, G Shafi, R Vashista, R Kumar, A Munshi
European journal of clinical pharmacology 74 (10), 1291-1298, 2018
Interaction between topoisomerases and histone deacetylases: Role in cancer progression and therapeutic interventions
G Joshi, A Thakur, G Kaur, S Kalra, S Singh, R Kumar
Nova Science Publishers, Inc., 2017
E-pharmacophore guided discovery of pyrazolo [1, 5-c] quinazolines as dual inhibitors of topoisomerase-I and histone deacetylase
G Joshi, S Kalra, UP Yadav, P Sharma, PK Singh, S Amrutkar, AJ Ansari, ...
Bioorganic chemistry 94, 103409, 2020
The system can't perform the operation now. Try again later.
Articles 1–20